DE69233678D1 - Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren - Google Patents

Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren

Info

Publication number
DE69233678D1
DE69233678D1 DE69233678T DE69233678T DE69233678D1 DE 69233678 D1 DE69233678 D1 DE 69233678D1 DE 69233678 T DE69233678 T DE 69233678T DE 69233678 T DE69233678 T DE 69233678T DE 69233678 D1 DE69233678 D1 DE 69233678D1
Authority
DE
Germany
Prior art keywords
agglomerates
weight
isobutylphenyl
pct
propionic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69233678T
Other languages
English (en)
Other versions
DE69233678T2 (de
Inventor
Graham John Atkin
Peter Drew
John Leslie Turner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt Benckiser Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare UK Ltd filed Critical Reckitt Benckiser Healthcare UK Ltd
Publication of DE69233678D1 publication Critical patent/DE69233678D1/de
Application granted granted Critical
Publication of DE69233678T2 publication Critical patent/DE69233678T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69233678T 1991-09-06 1992-08-25 Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren Expired - Fee Related DE69233678T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919119052A GB9119052D0 (en) 1991-09-06 1991-09-06 Pharmaceutical compositions
GB9119052 1991-09-06
PCT/EP1992/001953 WO1993004676A1 (en) 1991-09-06 1992-08-25 High content ibuprofen agglomerates and process to prepare them

Publications (2)

Publication Number Publication Date
DE69233678D1 true DE69233678D1 (de) 2007-03-22
DE69233678T2 DE69233678T2 (de) 2008-01-24

Family

ID=10700981

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69233678T Expired - Fee Related DE69233678T2 (de) 1991-09-06 1992-08-25 Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren

Country Status (16)

Country Link
US (1) US5512302A (de)
EP (1) EP0602112B1 (de)
JP (1) JP3444597B2 (de)
KR (1) KR100253046B1 (de)
AT (1) ATE353213T1 (de)
AU (1) AU655673B2 (de)
CA (1) CA2116956C (de)
CZ (1) CZ282271B6 (de)
DE (1) DE69233678T2 (de)
FI (1) FI107878B (de)
GB (1) GB9119052D0 (de)
IL (1) IL103005A (de)
IN (1) IN174169B (de)
RU (1) RU2123841C1 (de)
WO (1) WO1993004676A1 (de)
ZA (1) ZA926709B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101039B (fi) * 1992-10-09 1998-04-15 Eeva Kristoffersson Menetelmä lääkepellettien valmistamiseksi
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6726929B1 (en) 1998-12-18 2004-04-27 Basf Aktiengesellschaft Pharmaceutical mixture comprising a profen
US6251945B1 (en) * 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
DE10003757A1 (de) 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
US20040173147A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
US20040173146A1 (en) * 2001-06-07 2004-09-09 Figueroa Iddys D. Application of a bioactive agent to a delivery substrate
US6962715B2 (en) * 2001-10-24 2005-11-08 Hewlett-Packard Development Company, L.P. Method and dosage form for dispensing a bioactive substance
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
US20050203482A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical dispensing apparatus and method
US20050202051A1 (en) * 2004-03-15 2005-09-15 Chinea Vanessa I. Pharmaceutical vehicle
JP2008266270A (ja) * 2007-04-25 2008-11-06 Kowa Co イブプロフェン、トラネキサム酸及び糖アルコールを含有する固形製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92752T1 (de) * 1987-07-08 1993-08-15 American Home Prod Spruehgetrocknete ibuprofen-zusammensetzungen.
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
US5266723A (en) * 1989-05-16 1993-11-30 Medice, Ltd., Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
US5332834A (en) * 1992-12-02 1994-07-26 Hoechst Celanese Corporation Racemization of an enantomerically enriched α-aryl carboxylic acid

Also Published As

Publication number Publication date
IL103005A (en) 1996-01-19
CZ49994A3 (en) 1994-07-13
JPH06510532A (ja) 1994-11-24
US5512302A (en) 1996-04-30
AU655673B2 (en) 1995-01-05
RU2123841C1 (ru) 1998-12-27
CA2116956A1 (en) 1993-03-18
FI941046A (fi) 1994-03-04
CZ282271B6 (cs) 1997-06-11
FI941046A0 (fi) 1994-03-04
KR100253046B1 (ko) 2000-05-01
IL103005A0 (en) 1993-01-31
JP3444597B2 (ja) 2003-09-08
DE69233678T2 (de) 2008-01-24
ZA926709B (en) 1993-04-28
ATE353213T1 (de) 2007-02-15
EP0602112A1 (de) 1994-06-22
EP0602112B1 (de) 2007-02-07
AU2487092A (en) 1993-04-05
IN174169B (de) 1994-10-01
WO1993004676A1 (en) 1993-03-18
FI107878B (fi) 2001-10-31
CA2116956C (en) 2002-07-16
GB9119052D0 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
DE69105106T2 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
DE69424487T2 (de) Formulierung enthaltend einen antibakteriellen und einen Antiulcus Wirkstoff
DE69916922T2 (de) Ibuprofenhaltige Arzneizubereitung
JP4017661B2 (ja) 重合体マトリックス中の作用物質の固溶体の形の作用物質調剤の製法及び該製法により製造された作用物質調剤
DE69233678D1 (de) Agglomerate mit hohem ibuprofen-gehalt und deren herstellungsverfahren
AU2002238848B2 (en) Use of a spray-dried powder comprising a sugar alcohol
KR920009404A (ko) 위 체류 시간 지연성 제산제
DE102005026755A1 (de) Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
KR960016204B1 (ko) 비스테로이드성 소염제를 함유하는 약제학적 제제
EP0715857A2 (de) Pharmazeutische, oral anwendbare Zubereitungen enthaltend als Zerfallbeschleuniger eine wasserlösliche Aminosäure
KR960021061A (ko) 경구 투여용 약제학적 조성물
JPS5978116A (ja) スクラルフェ−ト製剤
Pandit et al. In vitro-in vivo evaluation of fast-dissolving tablets containing solid dispersion of pioglitazone hydrochloride
AU670048B2 (en) Immediate-effect ibuprofen-containing medicament and its use
JPS59181224A (ja) 安定なインタ−フエロン製剤の製法
JPH0813736B2 (ja) 単斜結晶構造を有する熱―、光―、及び湿気―感受性活性成分を含む錠剤又は糖剤組成物の調製方法
RU94019417A (ru) Способ получения фармацевтической композиции, фармацевтическая композиция, фармацевтический препарат, способы получения фармацевтического препарата
DE69910188T2 (de) Arzneiformen enthaltend carvedilol
JP2891744B2 (ja) パントテン酸カルシウム組成物およびその製造方法
JPS59148718A (ja) ユビデカレノン組成物
Burt et al. Electron microscope evidence of mitochondrial change in small intestine associated with administration of 20-methylcholanthrene
WO2014094956A1 (de) Magnesiumhydroxidcarbonat als träger in pharmazeutischen zubereitungen mit verbesserter wirkstofffreisetzung
JP2004075594A (ja) 経口用ウコン類組成物
PT1796730E (pt) Produto farmacêutico que contém leucotrieno b4 (ltb4) estabilizado
JP2000007556A (ja) チュアブル錠

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee